| Dear Voornaam, At Cancer Research UK, we fund over £400m of world-class cancer research each year. But we know our world-leading research is not progressing quickly enough from the lab to patients. I’m thrilled to announce that from today, we’re uniting all our drug discovery and commercialisation activity into one powerful innovation engine – Cancer Research Horizons. We’ll harness the full potential of the exciting cancer research happening globally by working together with the brightest minds, boldest ideas, and best partners, to translate cutting-edge innovations into tools, tests and treatments for cancer patients. An integral part of Cancer Research Horizons is our exciting and ambitious approach to driving therapeutic innovation. We’re uniting the strengths of our established drug discovery engines, our network of world-class biology researchers, ground-breaking technology platforms and clinical expertise. The new organisation will be home to over 200 drug discovery scientists and will use cutting-edge capabilities to tackle the biggest challenges in discovering cancer drugs. We're here to help you unlock the clinical and commercial potential of your research. There are many ways we can support you to develop your most promising projects – discover more below. I’m excited to see the translation of innovative science into effective treatments and diagnostics and I look forward to working with you. Follow Cancer Research Horizons on Twitter and LinkedIn to keep up to date on our latest developments.
Kind regards, Iain Foulkes Chief Executive Officer Cancer Research Horizons |
|
|---|
|
|---|
|
|
| | DISCOVER OUR NEW APPROACH TO THERAPEUTIC INNOVATION Access our drug discovery engines, cutting-edge technology platforms and network of world-class scientists and clinical experts. |
|
|---|
|
|---|
|
|
 TRANSLATE YOUR RESEARCH WITH US Translating your research means taking it from the lab and transforming it into effective tools, tests and treatments for cancer patients – and there are several ways to do this. We're here to discuss your ideas and provide advice and support on the next steps in translating your research. |
|
|---|
|  START YOUR ENTREPRENEURIAL JOURNEY WITH US We want to inspire the next generation of scientific entrepreneurs. Translating your research might seem complex, but we’re here to guide you through it. Our entrepreneurial programmes provide training and support that will help you build a business. |
|
|---|
|
|---|
|
|
| | BRINGING IMPACT TO PEOPLE AFFECTED BY CANCER To date, we’ve played an instrumental role in bringing 11 new cancer drugs to market and forming over 60 startup companies – but that’s not all. Read the stories from the teams behind some of our most important achievements, from bringing drugs to market to spinning out new companies and developing essential partnerships. |
|
|---|
|
|---|
|
|
| | FGC ACCEPTING CRISPR SCREENING PROJECT PROPOSALS Our Functional Genomics Centre (FGC) provides Cancer Research UK-funded researchers access to genome-wide, pooled CRISPR screening capabilities. If your research could benefit from our state-of-the-art CRISPR technology, we’d love to work with you to progress your research. We review and accept proposals every 2 months; the next deadline is 15 June. |
|
|---|
|
|---|
|
|
| | ATTEND OUR INNOVATION SUMMIT Our Innovation Summit returns this year in Newcastle on 26 May. Reserve your free place to hear from successful entrepreneurs who have commercialised their research, and learn from members of the local entrepreneurial ecosystem, our partners and industry professionals. Confirmed speakers include: - Tony Hickson, Cancer Research Horizons' Chief Business Officer
- David Burn, Director of Newcastle Health Innovation Partners
- Ruth Plummer, Professor of Experimental Cancer Medicine at Newcastle University
- David Simpson – CEO, co-founder, Iksuda Therapeutics
- Martina Miotto, Chief Scientific Officer of CellulaREvolution
|
|
|---|
|
|---|
|
|
 REGISTER FOR OUR ENTREPRNEURIAL TRAINING SEMINAR Join us on 12 May for the first session of our entrepreneurial training seminar series, in partnership with Start Codon. Dr Jason Mellad, CEO of Start Codon, will share his experiences of starting and growing a business from the ground up. The session will cover high-level topics such as why and when you might wish to start a business or spin-out from an institution, while outlining associated key challenges and how to overcome them. You can join in-person or online. |
|
|---|
|  PROGRESS YOUR RESEARCH THROUGH THE ONCOSTARS ACTION PROGRAMME Whether you have a budding research idea or a start-up that aims to diagnose, treat or prevent cancer, you can apply to our OncoStars Action programme with Panacea Stars. It’s a programme that will inspire you to think about your research differently. We'll show you how an entrepreneur approaches research and support you to commercially develop your ideas to benefit people with cancer. You will receive entrepreneurial training, access to professional networks, mentoring from industry experts, and a tailored pipeline and market strategy to suit your needs. |
|
|---|
|
|---|
|
|
| | KEEP UP TO DATE WITH CANCER RESEARCH HORIZONS Look out for more Cancer Research Horizons-related news and opportunities for researchers in our future Research Update newsletters. Please forward this email to colleagues who may be interested. You can also follow us on Twitter and LinkedIn to keep up to date on our latest developments in drug discovery and commercialisation. |
|
|---|
|
|---|
|
|
| | SIGN UP TO OUR NEWSLETTER If you've been forwarded this email, subscribe to our newsletter to stay up to date. |
|
|---|
|
|---|
|
|
|
